MoneyWorks4Me

Viyash Scientific informs about investor presentation

06 Feb 2026 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Viyash Scientific has informed that it enclosed Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025. 

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1210.50
Cipla 1369.10
Lupin 2120.00
Zydus Lifesciences 1167.25
View more..